Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring 17.13% Upside Potential in the Healthcare SectorAmphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a key player in the healthcare sector, operates within the niche of specialty and generic drug manufacturing. Currently trading at $27.89, Amphastar’s stock has demonstrated notable volatility, oscillating between $20.62 and $53.40 over the past year. This price range provides a compelling entry point for investors considering the potential upside of 17.13%, as inferred from the average target price of $32.67 set by analysts. The target price range of $25.00 to $38.00 further supports the potential for price appreciation, aligning with the broader market’s expectation of growth. Investors considering Amphastar Pharmaceuticals should weigh its potential for growth against the backdrop of current market trends and financial health.